It would also have exactly zero bearing on advancing this vaccine toward approval, and if that were all that happened the share price would plummet next week. What you describe is pretty much exactly what they did last year, minus LL. I mean, don't you people ever learn?
Let's have the data, the proof. Anything other than that is more of the same: delays, delays, delays. One of these days you folks are going to figure out why we never seem to get that data and that proof. One of these days you folks are going to figure out why they are always "moving toward" unblinding but never actually getting there.
I hope they prove me wrong, but I'm definitely not counting on it. From a conversation with David Innes that was reported on this message board barely a week ago, they haven't even finished the SAPs, and they haven't locked the data. Based on those simple facts, assuming the conversation was reported accurately, they are still playing games.